Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 4/2021

06.03.2021 | COVID-19 | Systematic Reviews and Meta-analyses Zur Zeit gratis

Laparoscopic surgery during the COVID-19 pandemic: detection of SARS-COV-2 in abdominal tissues, fluids, and surgical smoke

verfasst von: Isaac Cheruiyot, Prabjot Sehmi, Brian Ngure, Musa Misiani, Paul Karau, Beda Olabu, Brandon Michael Henry, Giuseppe Lippi, Roberto Cirocchi, Julius Ogeng’o

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

There are still concerns over the safety of laparoscopic surgery in coronavirus disease 2019 (COVID-19) patients due to the potential risk of viral transmission through surgical smoke/laparoscopic pneumoperitoneum.

Methods

We performed a systematic review of currently available literature to determine the presence of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) in abdominal tissues or fluids and in surgical smoke.

Results

A total of 19 studies (15 case reports and 4 case series) comprising 29 COVID-19 patients were included. The viral RNA was positively identified in 11 patients (37.9%). The samples that tested positive include the peritoneal fluid, bile, ascitic fluid, peritoneal dialysate, duodenal wall, and appendix. Similar samples, together with the omentum and abdominal subcutaneous fat, tested negative in the other patients. Only one study investigated SARS-COV-2 RNA in surgical smoke generated during laparoscopy, reporting negative findings.

Conclusions

There are conflicting results regarding the presence of SARS-COV-2 in abdominal tissues and fluids. No currently available evidence supports the hypothesis that SARS-COV-2 can be aerosolized and transmitted through surgical smoke. Larger studies are urgently needed to corroborate these findings.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Di Saverio S, Khan M, Pata F, Ietto G, De Simone B, Zani E et al (2020) Laparoscopy at all costs? Not now during COVID-19 outbreak and not for acute care surgery and emergency colorectal surgery: a practical algorithm from a hub tertiary teaching hospital in Northern Lombardy, Italy. J Trauma Acute Care Surg 88(6):715–718CrossRef Di Saverio S, Khan M, Pata F, Ietto G, De Simone B, Zani E et al (2020) Laparoscopy at all costs? Not now during COVID-19 outbreak and not for acute care surgery and emergency colorectal surgery: a practical algorithm from a hub tertiary teaching hospital in Northern Lombardy, Italy. J Trauma Acute Care Surg 88(6):715–718CrossRef
4.
Zurück zum Zitat Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X et al (2020) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 12(1):1–5CrossRef Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X et al (2020) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 12(1):1–5CrossRef
5.
Zurück zum Zitat Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, Yin H, Xiao Q, Tang Y, Qu X, Kuang L, Fang X, Mishra N, Lu J, Shan H, Jiang G, Huang X (2020) Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 5(5):434–435CrossRef Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, Yin H, Xiao Q, Tang Y, Qu X, Kuang L, Fang X, Mishra N, Lu J, Shan H, Jiang G, Huang X (2020) Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 5(5):434–435CrossRef
6.
Zurück zum Zitat Henry BM, de Oliveira MHS, Benoit J, Lippi G (2020) Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis. Intern Emerg Med Henry BM, de Oliveira MHS, Benoit J, Lippi G (2020) Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis. Intern Emerg Med
7.
Zurück zum Zitat Gupta N, Agrawal H (2020) COVID 19 and laparoscopic surgeons, the Indian scenario - Perspective. Int J Surg Lond Engl 79:165–167CrossRef Gupta N, Agrawal H (2020) COVID 19 and laparoscopic surgeons, the Indian scenario - Perspective. Int J Surg Lond Engl 79:165–167CrossRef
8.
Zurück zum Zitat Mintz Y, Arezzo A, Boni L, Baldari L, Cassinotti E, Brodie R, Uranues S, Zheng MH, Fingerhut A (2020) The risk of COVID-19 transmission by laparoscopic smoke may be lower than for laparotomy: a narrative review. Surg Endosc 34(8):3298–3305CrossRef Mintz Y, Arezzo A, Boni L, Baldari L, Cassinotti E, Brodie R, Uranues S, Zheng MH, Fingerhut A (2020) The risk of COVID-19 transmission by laparoscopic smoke may be lower than for laparotomy: a narrative review. Surg Endosc 34(8):3298–3305CrossRef
9.
Zurück zum Zitat Vigneswaran Y, Prachand VN, Posner MC, Matthews JB, Hussain M (2020) What is the appropriate use of laparoscopy over open procedures in the current COVID-19 climate? J Gastrointest Surg. 1–6 Vigneswaran Y, Prachand VN, Posner MC, Matthews JB, Hussain M (2020) What is the appropriate use of laparoscopy over open procedures in the current COVID-19 climate? J Gastrointest Surg. 1–6
10.
Zurück zum Zitat Kwak HD, Kim S-H, Seo YS, Song K-J (2016) Detecting hepatitis B virus in surgical smoke emitted during laparoscopic surgery. Occup Environ Med 73(12):857–863PubMed Kwak HD, Kim S-H, Seo YS, Song K-J (2016) Detecting hepatitis B virus in surgical smoke emitted during laparoscopic surgery. Occup Environ Med 73(12):857–863PubMed
11.
Zurück zum Zitat Sawchuk WS, Weber PJ, Lowy DR, Dzubow LM (1989) Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: detection and protection. J Am Acad Dermatol 21(1):41–49CrossRef Sawchuk WS, Weber PJ, Lowy DR, Dzubow LM (1989) Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: detection and protection. J Am Acad Dermatol 21(1):41–49CrossRef
12.
Zurück zum Zitat Johnson GK, Robinson WS (1991) Human immunodeficiency virus-1 (HIV-1) in the vapors of surgical power instruments. J Med Virol 33(1):47–50CrossRef Johnson GK, Robinson WS (1991) Human immunodeficiency virus-1 (HIV-1) in the vapors of surgical power instruments. J Med Virol 33(1):47–50CrossRef
13.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRef
14.
Zurück zum Zitat Seeliger B, Philouze G, Benotmane I, Mutter D, Pessaux P (2020) Is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present intraperitoneally in patients with coronavirus disease 2019 (COVID-19) infection undergoing emergency operations? Surgery. 168(2):220–221CrossRef Seeliger B, Philouze G, Benotmane I, Mutter D, Pessaux P (2020) Is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present intraperitoneally in patients with coronavirus disease 2019 (COVID-19) infection undergoing emergency operations? Surgery. 168(2):220–221CrossRef
15.
Zurück zum Zitat Ying M, Lu B, Pan J, Lu G, Zhou S, Wang D et al (2020) COVID-19 with acute cholecystitis: a case report. BMC Infect Dis 20(1):1–4CrossRef Ying M, Lu B, Pan J, Lu G, Zhou S, Wang D et al (2020) COVID-19 with acute cholecystitis: a case report. BMC Infect Dis 20(1):1–4CrossRef
19.
Zurück zum Zitat Culver A, Arbelot C, Bechis C, Cassir N, Leone M (2020) First description of SARS-CoV-2 in ascites. IDCases. 21:e00836CrossRef Culver A, Arbelot C, Bechis C, Cassir N, Leone M (2020) First description of SARS-CoV-2 in ascites. IDCases. 21:e00836CrossRef
20.
Zurück zum Zitat Ngaserin SH-N, Koh FH, Ong B-C, Chew M-H (2020) COVID-19 not detected in peritoneal fluid: a case of laparoscopic appendicectomy for acute appendicitis in a COVID-19-infected patient. Langenbeck's Arch Surg 9:1–3 Ngaserin SH-N, Koh FH, Ong B-C, Chew M-H (2020) COVID-19 not detected in peritoneal fluid: a case of laparoscopic appendicectomy for acute appendicitis in a COVID-19-infected patient. Langenbeck's Arch Surg 9:1–3
21.
Zurück zum Zitat Vischini G, D’Alonzo S, Grandaliano G, D’Ascenzo FM (2020) SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis. Kidney Int 98(1):237–238CrossRef Vischini G, D’Alonzo S, Grandaliano G, D’Ascenzo FM (2020) SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis. Kidney Int 98(1):237–238CrossRef
22.
Zurück zum Zitat Federico C, Dario T, Adolfo P, Cesira G, Mauro P, Marianna L, et al. (2020) SARS-CoV-2 is present in peritoneal fluid in COVID-19 patients. In Press Federico C, Dario T, Adolfo P, Cesira G, Mauro P, Marianna L, et al. (2020) SARS-CoV-2 is present in peritoneal fluid in COVID-19 patients. In Press
26.
Zurück zum Zitat Passarelli VC, Perosa AH, de Souza Luna LK, Conte DD, Nascimento OA, Ota-Arakaki J et al (2020) Detected SARS-CoV-2 in ascitic fluid followed by cryptococcemia: a case report. Sn Compr Clin Med 8:1–5 Passarelli VC, Perosa AH, de Souza Luna LK, Conte DD, Nascimento OA, Ota-Arakaki J et al (2020) Detected SARS-CoV-2 in ascitic fluid followed by cryptococcemia: a case report. Sn Compr Clin Med 8:1–5
27.
Zurück zum Zitat Scutari R, Piermatteo L, Ciancio Manuelli M, Iannetta M, Salpini R, Bertoli A, et al. (2020) Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids including bile in two patients with acute cholecystitis. Life Basel Switz. 10(11) Scutari R, Piermatteo L, Ciancio Manuelli M, Iannetta M, Salpini R, Bertoli A, et al. (2020) Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids including bile in two patients with acute cholecystitis. Life Basel Switz. 10(11)
28.
Zurück zum Zitat Agnes A, La Greca A, Tirelli F, Papa V (2020) Duodenal perforation in a SARS-CoV-2-positive patient with negative PCR results for SARS-CoV-2 in the peritoneal fluid. Eur Rev Med Pharmacol Sci 24(23):12516–12521PubMed Agnes A, La Greca A, Tirelli F, Papa V (2020) Duodenal perforation in a SARS-CoV-2-positive patient with negative PCR results for SARS-CoV-2 in the peritoneal fluid. Eur Rev Med Pharmacol Sci 24(23):12516–12521PubMed
30.
Zurück zum Zitat Liao Y, Wang B, Wang J, Shu J, Zhou W, Zhang H (2020) SARS-CoV-2 in the bile of a patient with COVID-19-associated gallbladder disease. Endoscopy. 52(12):1148–1148CrossRef Liao Y, Wang B, Wang J, Shu J, Zhou W, Zhang H (2020) SARS-CoV-2 in the bile of a patient with COVID-19-associated gallbladder disease. Endoscopy. 52(12):1148–1148CrossRef
31.
Zurück zum Zitat Candellier A, Scohy A, Gillet N, Muylkens B, Morelle J, Belkhir L, Coupeau D, Jadoul M, Goffin É (2020) Absence of SARS-CoV-2 in the effluent of peritoneal dialysis patients. Perit Dial Int 40(5):499–503CrossRef Candellier A, Scohy A, Gillet N, Muylkens B, Morelle J, Belkhir L, Coupeau D, Jadoul M, Goffin É (2020) Absence of SARS-CoV-2 in the effluent of peritoneal dialysis patients. Perit Dial Int 40(5):499–503CrossRef
32.
Zurück zum Zitat Sadioglu RE, Aktar M, Gulten E, Eyupoglu S, Karahan ZC, Azap A, Sengul S, Ates K, Kutlay S (2020) Does SARS-CoV-2 reach peritoneal effluent? Perit Dial Int 40(5):520–521CrossRef Sadioglu RE, Aktar M, Gulten E, Eyupoglu S, Karahan ZC, Azap A, Sengul S, Ates K, Kutlay S (2020) Does SARS-CoV-2 reach peritoneal effluent? Perit Dial Int 40(5):520–521CrossRef
35.
Zurück zum Zitat Feig BW (2005) Role of laparoscopy in gastrointestinal malignancies. In: Ajani JA, Lynch PM, Janjan NA, Curley SA, editors. Gastrointestinal Cancer [Internet]. New York, NY: Springer [cited 2020 Jul 28]. p. 58–66. (M. D. Anderson Cancer Care Series). Available from: https://doi.org/10.1007/0-387-27285-2_5 Feig BW (2005) Role of laparoscopy in gastrointestinal malignancies. In: Ajani JA, Lynch PM, Janjan NA, Curley SA, editors. Gastrointestinal Cancer [Internet]. New York, NY: Springer [cited 2020 Jul 28]. p. 58–66. (M. D. Anderson Cancer Care Series). Available from: https://​doi.​org/​10.​1007/​0-387-27285-2_​5
36.
Zurück zum Zitat Woloshin S, Patel N, Kesselheim AS (2020) False negative tests for SARS-CoV-2 infection — challenges and implications. N Engl J Med. 0(0):null Woloshin S, Patel N, Kesselheim AS (2020) False negative tests for SARS-CoV-2 infection — challenges and implications. N Engl J Med. 0(0):null
37.
Zurück zum Zitat Lippi G, Simundic A-M, Plebani M (2020) Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med 58(7):1070–1076CrossRef Lippi G, Simundic A-M, Plebani M (2020) Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med 58(7):1070–1076CrossRef
38.
Zurück zum Zitat Atkinson B, Petersen E (2020) SARS-CoV-2 shedding and infectivity. Lancet Lond Engl 395(10233):1339–1340CrossRef Atkinson B, Petersen E (2020) SARS-CoV-2 shedding and infectivity. Lancet Lond Engl 395(10233):1339–1340CrossRef
39.
Zurück zum Zitat Andersson M, Carcamo CVA, Auckland K, Baillie JK, Barnes E, Beneke T, et al. (2020) SARS-CoV-2 RNA detected in blood samples from patients with COVID-19 is not associated with infectious virus. medRxiv. 2020.05.21.20105486 Andersson M, Carcamo CVA, Auckland K, Baillie JK, Barnes E, Beneke T, et al. (2020) SARS-CoV-2 RNA detected in blood samples from patients with COVID-19 is not associated with infectious virus. medRxiv. 2020.05.21.20105486
41.
Zurück zum Zitat Carter B, Collins JT, Barlow-Pay F, Rickard F, Bruce E, Verduri A, Quinn TJ, Mitchell E, Price A, Vilches-Moraga A, Stechman MJ, Short R, Einarsson A, Braude P, Moug S, Myint PK, Hewitt J, Pearce L, McCarthy K, Davey C, Jones S, Lunstone K, Cavenagh A, Silver C, Telford T, Simmons R, Holloway M, Hesford J, el Jichi Mutasem T, Singh S, Paxton D, Harris W, Galbraith N, Bhatti E, Edwards J, Duffy S, Kelly J, Murphy C, Bisset C, Alexander R, Garcia M, Sangani S, Kneen T, Lee T, McGovern A, Guaraldi G, Clini E (2020) Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople). J Hosp Infect 106(2):376–384CrossRef Carter B, Collins JT, Barlow-Pay F, Rickard F, Bruce E, Verduri A, Quinn TJ, Mitchell E, Price A, Vilches-Moraga A, Stechman MJ, Short R, Einarsson A, Braude P, Moug S, Myint PK, Hewitt J, Pearce L, McCarthy K, Davey C, Jones S, Lunstone K, Cavenagh A, Silver C, Telford T, Simmons R, Holloway M, Hesford J, el Jichi Mutasem T, Singh S, Paxton D, Harris W, Galbraith N, Bhatti E, Edwards J, Duffy S, Kelly J, Murphy C, Bisset C, Alexander R, Garcia M, Sangani S, Kneen T, Lee T, McGovern A, Guaraldi G, Clini E (2020) Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople). J Hosp Infect 106(2):376–384CrossRef
Metadaten
Titel
Laparoscopic surgery during the COVID-19 pandemic: detection of SARS-COV-2 in abdominal tissues, fluids, and surgical smoke
verfasst von
Isaac Cheruiyot
Prabjot Sehmi
Brian Ngure
Musa Misiani
Paul Karau
Beda Olabu
Brandon Michael Henry
Giuseppe Lippi
Roberto Cirocchi
Julius Ogeng’o
Publikationsdatum
06.03.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 4/2021
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-021-02142-8

Weitere Artikel der Ausgabe 4/2021

Langenbeck's Archives of Surgery 4/2021 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.